HSA Expands Global Regulatory Pathways

These initiatives kickstarts 2026 with a strong expanded regulatory access, shortened approval timelines, and promoted convergence with trusted authorities.

The recent partnerships with the UK, Malaysia and Hong Kong mark a significant shift toward coordinated reviews, reliance models and regulatory cooperation, benefiting innovators and patients alike.